The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial)

Mult Scler. 2023 May;29(6):668-670. doi: 10.1177/13524585231161148. Epub 2023 Mar 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Child
  • Crotonates / therapeutic use
  • Humans
  • Intermediate Filaments
  • Multiple Sclerosis* / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting* / drug therapy
  • Neurofilament Proteins
  • Randomized Controlled Trials as Topic
  • Toluidines / therapeutic use

Substances

  • Crotonates
  • Neurofilament Proteins
  • teriflunomide
  • Toluidines